Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
entities : Agenus inc. symbols : AZNCF save search
CTLA4 (Cytotoxic T-Lymphocyte-Associated Protein 4) Inhibitors Market to grow by USD 2.23 billion between 2023 and 2028, growth Driven by High target affinity and specificity of CTLA4 inhibitors - Technavio
Published: 2024-01-26 (Crawled : 02:00) - prnewswire.com
XLO | $1.28 4.06% 0.0% 130K
|
Professional, Scientific, and T...
|
| O: 4.69%
H: 4.55%
C: -2.99%
AZNCF | $138.24 -1.36% -4.19% 800
|
Health Technology
|
| O: 2.92%
H: 1.06%
C: -3.05%
BNTX | $86.17 -0.27% -0.24% 520K
|
Health Technology
|
| O: -1.35%
H: 0.12%
C: -0.83%
AZN | $68.36 -0.25% -0.25% 3.6M
|
Health Technology
|
| O: 1.07%
H: 0.1%
C: -0.94%
AGEN | $4.97 -7.96% -8.65% 1.6M
|
Health Technology
|
| O: 3.13%
H: 11.02%
C: 7.11%
protein growth market
PD-1 And PD-L1 Inhibitors Market to Grow by USD 29.97 billion| Reduction in Cancer Mortality Rate to Boost Market Growth | 17,000+ Technavio Research Reports
Published: 2022-01-13 (Crawled : 11:00) - prnewswire.com
AZNCF | $138.24 -1.36% -4.19% 800
|
Health Technology
|
| O: 2.17%
H: 0.07%
C: -0.53%
AZN | $68.36 -0.25% -0.25% 3.6M
|
Health Technology
|
| O: 1.0%
H: 0.02%
C: -0.99%
AMGN | $262.75 -0.5% -0.49% 1.4M
|
Health Technology
|
| O: -0.15%
H: 0.0%
C: 0.0%
AGEN | $4.97 -7.96% -8.65% 1.6M
|
Health Technology
|
| O: -2.28%
H: 1.67%
C: -3.67%
research cancer growth
Gainers vs Losers
| 59% | 41% |
Top 10 Gainers
AGBA | News | $1.03 157.5% 57.94% 120M
|
Finance
ZCMD | $1.45 5.84% 52.1% 2.3M
|
Commercial Services
INVO | $1.52 100.0% 51.13% 5M
|
Health Technology
ISPC | $0.421 97.65% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | News | $0.5 45.65% 470K
|
OST | $0.509 23.81% 45.26% 90K
|
GDHG | $0.263 21.76% 40.66% 3.1M
|
XPON | News | $3.15 63.21% 37.74% 16M
|
TIRX | $0.8 65.02% 30.74% 58M
|
BNTC | News | $6.82 42.08% 30.64% 3.5M
|
Health Technology
Your saved searches
Save your searches and get alerts when important news are released.